VIVUS (VVUSQ) News Today $0.12 0.00 (0.00%) (As of 12/17/2020) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period VIVUS and UpScriptHealth Announce Launch of ChooseQ.online for Access to Advanced Weight Management SolutionsOctober 30, 2024 | markets.businessinsider.comVIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and PolandOctober 7, 2024 | markets.businessinsider.comTimber Rattlesnake vs. Eastern Diamondback: What Sets These Fanged Serpents Apart?August 19, 2024 | msn.comIcahn Enterprises L.P. (NASDAQ:IEP) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | msn.comWeight Loss Drugs Market Size to Hit US$ 45.35 Billion By 2032, With a Growing CAGR of 43.73% | Research by SNS InsiderJuly 23, 2024 | finance.yahoo.comPorsche's Hybrid 911 Is Finally Coming After 3 Million Miles Of TestingMay 14, 2024 | msn.comPorsche is debuting a new hybrid 911 sports carMay 13, 2024 | msn.comHybrid 911 Coming 2025, but Ferdinand Porsche Invented World's First Hybrid in 1899May 13, 2024 | msn.comFerdinand Porsche’s Gas-Electric Hybrid TanksApril 24, 2024 | yahoo.comVIVUS Announces it will Provide Telehealth to Patients through an Enhanced 'Engage' Program in Collaboration with UpScriptHealthApril 22, 2024 | finance.yahoo.comAnti-obesity Drugs market is estimated to grow at a CAGR of 21.2% by 2034: VisiongainApril 12, 2024 | uk.finance.yahoo.comUS pharma giant Eli Lilly plans to introduce its blockbuster anti-diabetes drug Mounjaro to India next year, to target weight loss marketFebruary 28, 2024 | msn.comWeight-loss drugs for teens are controversial. A 16-year-old taking Wegovy shares her storyFebruary 9, 2024 | msn.comThe First Porsche With All-Wheel Drive Was An Off-Road Military VehicleJanuary 27, 2024 | msn.comNorovirus, aka stomach flu, on the rise in the US: Know these signsJanuary 5, 2024 | msn.comGustav Mahler: Eighth Symphony: Part TwoDecember 30, 2023 | bbc.co.ukWhy pharma majors are rushing to put anti-obesity drugs on Indian shelvesDecember 23, 2023 | msn.comErectile Dysfunction (ED) Drugs Market to grow by USD 1.44 billion from 2023-2028, North America to account for 41% of market growth - TechnavioDecember 14, 2023 | finance.yahoo.comCaledon residents donate $500,000 to Headwaters Health Care FoundationDecember 7, 2023 | ca.news.yahoo.comWhat Is Barre? Everything to Know About This Low-Impact, High-Intensity WorkoutDecember 7, 2023 | ca.sports.yahoo.comTeens who use phones for over 4 hours daily face higher health risks: studyDecember 7, 2023 | ca.sports.yahoo.comCharlotte hospitals change visitor guidelines due to rising COVID-19, flu and RSV casesDecember 7, 2023 | ca.sports.yahoo.comHospital Pushed Weight-Loss Surgery on Prisoners Who Recovered in Jail: NYTDecember 7, 2023 | ca.news.yahoo.comFree at-home testing and treatments now available for COVID and flu through federal programDecember 6, 2023 | ca.sports.yahoo.comSaskatchewan auditor reports longer waits for neurosurgeries; more homelessnessDecember 6, 2023 | ca.news.yahoo.comBoris Johnson admits he should 'twigged the risk' of Covid earlierDecember 6, 2023 | ca.sports.yahoo.comThis Is How I Finally Got My Tubes Removed After Years Of Doctors Fighting Me On ItDecember 6, 2023 | ca.news.yahoo.comAdherence to weight-loss drugs is far higher with Wegovy than older medicinesDecember 6, 2023 | reuters.comAnti-Obesity Drugs Market is forecasted to reach USD 8.2 billion by 2032, growing at a 14.6% CAGR from 2023 to 2032October 3, 2023 | finance.yahoo.comWegovy, other weight-loss drugs scrutinized over reports of suicidal thoughtsSeptember 28, 2023 | reuters.comEU regulators warn pregnant women not to use topiramateSeptember 1, 2023 | msn.comStudy finds Wegovy least cost-effective drug option for teen weight lossAugust 31, 2023 | msn.comEU investigates Ozempic, weight-loss drug Saxenda after patients report suicidal thoughtsJuly 10, 2023 | theglobeandmail.comE.U. investigates Ozempic and weight-loss drug Saxenda after reports of suicidal thoughtsJuly 10, 2023 | nbcnews.comEU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reportedJuly 10, 2023 | msn.comYou Might Be Using Your 4-Wheel Drive Wrong – Here's The Right WayJuly 10, 2023 | msn.comHistoric Portsmouth vessel transformed into 1940s style restaurant offering views across The SolentJune 18, 2023 | msn.comFour Drug Stocks Facing FDA Approval Decisions in JulyJune 10, 2023 | thestreet.comOrexigen: 'Goldilocks' Obesity Pill Awaits FDA Approval Decision WednesdayMay 24, 2023 | thestreet.comVivus Lives to Fight Another DayMay 7, 2023 | thestreet.comPhosphodiesterase Inhibitors Market Size with Growth Opportunities, Future Trends and Share with Revenue Forecast 2028May 5, 2023 | marketwatch.comWhy VIVUS (VVUS) Stock Is Up TodayMay 2, 2023 | thestreet.comPhosphodiesterase Inhibitors Market Analysis By Industry Size, Development And Demand Forecast 2028March 27, 2023 | marketwatch.comVIVUS Announces Key Management Updates to Support Global Expansion StrategyFebruary 5, 2023 | finance.yahoo.comPhosphodiesterase Inhibitors Market Global Industry Analysis By Development, Industry Analysis and Opportunity Assessment 2028May 31, 2022 | marketwatch.comPhosphodiesterase Inhibitors Market Industry Analysis Technological Innovations, Trends, Growth And Opportunity Assessment 2028April 26, 2022 | marketwatch.comPhosphodiesterase Inhibitors Market: Industry Analysis and Opportunity Assessment 2028January 19, 2022 | marketwatch.comPhosphodiesterase Inhibitors Market Share, Latest Trend Analysis, Revenue Expectation to 2028December 10, 2021 | marketwatch.com Get VIVUS News Delivered to You Automatically Sign up to receive the latest news and ratings for VVUSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. VVUSQ Media Mentions By Week VVUSQ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VVUSQ News Sentiment▼0.000.49▲Average Medical News Sentiment VVUSQ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VVUSQ Articles This Week▼00▲VVUSQ Articles Average Week Get VIVUS News Delivered to You Automatically Sign up to receive the latest news and ratings for VVUSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today Alvotech News Today American Premium Mining News Today Anew Medical News Today Arno Therapeutics News Today AstraZeneca News Today AVVAA World Health Care Products News Today Basilea Pharmaceutica News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:VVUSQ) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VIVUS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VIVUS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
